© 2001 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation
aInstitute of Child Health, University College London, London WC1N 1EH, UK
bHatter Institute of Cardiology, University College Hospitals, London, UK
cDepartment of Protein Sciences, Genentech Inc, South San Francisco, USA
dDepartment of Molecular Oncology, Genentech Inc, South San Francisco, USA
* Corresponding author. Tel.: +44-20-7905-2189; fax: +44-20-7242-8437 d.latchman{at}ich.ucl.ac.uk
Objective: The cytokine cardiotrophin-1 (CT-1) has previously been shown to protect cultured cardiocytes from cell death induced by serum removal or hypoxia when administered prior to the damaging stimulus. We wished to test whether a similar protective effect could be observed if CT-1 was added after the ischaemic period and to investigate the signalling pathways involved in the protective effect when CT-1 is given prior to or after ischaemia. Methods: We therefore examined the protective effect of CT-1 in cultured rat cardiocytes exposed to simulated ischaemia followed by reoxygenation when CT-1 was administered either prior to simulated ischaemia or at reoxygenation. Results: We show that CT-1 can exert a protective effect against the damaging effects of simulated ischaemia/reoxygenation both when added after the simulated ischaemia at reoxygenation (P<0.05 in trypan blue, TUNEL and annexin V assays) or when added prior to the simulated ischaemia (P<0.05). In both cases, these protective effects are blocked by an inhibitor of the p42/p44 MAPK pathway (P<0.05 in all assays). Conclusion: CT-1 can protect cardiac cells when added either prior to simulated ischaemia or at the time of reoxygenation following simulated ischaemia and these effects are dependent upon its ability to activate the p42/p44 MAPK pathway. Hence CT-1 may have therapeutic potential when added at the time of reperfusion following ischaemic damage.
KEYWORDS Apoptosis; Cell culture/isolation; Cytokines; Hypoxia/anoxia; Myocytes; Cardioplegia; Ischemia; Reperfusion
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. C. Parrish, E. N. Alston, H. Rohrer, S. M. Hermes, S. A. Aicher, P. Nkadi, W. R. Woodward, J. Stubbusch, R. T. Gardner, and B. A. Habecker Absence of gp130 in dopamine {beta}-hydroxylase-expressing neurons leads to autonomic imbalance and increased reperfusion arrhythmias Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H960 - H967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Hausenloy and D. M. Yellon Cardioprotective growth factors Cardiovasc Res, July 15, 2009; 83(2): 179 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Drobic, R. H. Cunnington, K. M. Bedosky, J. E. Raizman, V. V. Elimban, S. G. Rattan, and I. M. C. Dixon Differential and combined effects of cardiotrophin-1 and TGF-beta1 on cardiac myofibroblast proliferation and contraction Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1053 - H1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Lopez, N. Varo, J. Diez, and M. A. Fortuno Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists? Cardiovasc Res, August 1, 2007; 75(3): 536 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Iniguez, C. Berasain, E. Martinez-Anso, M. Bustos, P. Fortes, D. Pennica, M. A. Avila, and J. Prieto Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning J. Exp. Med., December 25, 2006; 203(13): 2809 - 2815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ateghang, M. Wartenberg, M. Gassmann, and H. Sauer Regulation of cardiotrophin-1 expression in mouse embryonic stem cells by HIF-1{alpha} and intracellular reactive oxygen species J. Cell Sci., March 15, 2006; 119(6): 1043 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kempf, M. Eden, J. Strelau, M. Naguib, C. Willenbockel, J. Tongers, J. Heineke, D. Kotlarz, J. Xu, J. D. Molkentin, et al. The Transforming Growth Factor-{beta} Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion Injury Circ. Res., February 17, 2006; 98(3): 351 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tsang, D. J. Hausenloy, and D. M. Yellon Myocardial postconditioning: reperfusion injury revisited Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H2 - H7. [Full Text] [PDF]
|
|
|
|
|
|
D. H. Freed, R. H. Cunnington, A. L. Dangerfield, J. S. Sutton, and I. M.C. Dixon Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart Cardiovasc Res, March 1, 2005; 65(4): 782 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J Hausenloy and D. M Yellon New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway Cardiovasc Res, February 15, 2004; 61(3): 448 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Brar, A. K. Jonassen, E. M. Egorina, A. Chen, A. Negro, M. H. Perrin, O. D. Mjos, D. S. Latchman, K.-F. Lee, and W. Vale Urocortin-II and Urocortin-III Are Cardioprotective against Ischemia Reperfusion Injury: An Essential Endogenous Cardioprotective Role for Corticotropin Releasing Factor Receptor Type 2 in the Murine Heart Endocrinology, January 1, 2004; 145(1): 24 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gonzalez, M. A Fortuno, R. Querejeta, S. Ravassa, B. Lopez, N. Lopez, and J. Diez Cardiomyocyte apoptosis in hypertensive cardiomyopathy Cardiovasc Res, September 1, 2003; 59(3): 549 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Fortuno, A. Gonzalez, S. Ravassa, B. Lopez, and J. Diez Clinical implications of apoptosis in hypertensive heart disease Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1495 - H1506. [Full Text] [PDF]
|
|
|
|
 |
|
 K.M. Lawrence, A. Chanalaris, T. Scarabelli, M. Hubank, E. Pasini, P.A. Townsend, L. Comini, R. Ferrari, A. Tinker, A. Stephanou, et al. KATP Channel Gene Expression Is Induced by Urocortin and Mediates Its Cardioprotective Effect Circulation, September 17, 2002; 106(12): 1556 - 1562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M Smith, S. Lecour, and M. N Sack Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program Cardiovasc Res, August 15, 2002; 55(3): 474 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liao, B. K. Brar, Q. Cai, A. Stephanou, R. M. O'Leary, D. Pennica, D. M. Yellon, and D. S. Latchman Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion Cardiovasc Res, March 1, 2002; 53(4): 902 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gusterson, B. Brar, D. Faulkes, A. Giordano, J. Chrivia, and D. Latchman The Transcriptional Co-activators CBP and p300 Are Activated via Phenylephrine through the p42/p44 MAPK Cascade J. Biol. Chem., January 18, 2002; 277(4): 2517 - 2524. [Abstract] [Full Text] [PDF]
|
|